Načítá se...
Differential effects of rapalogues, dual kinase inhibitors on human ovarian carcinoma cells in vitro
Ovarian cancer is the second most common gynaecological malignancy and was diagnosed in over 7,000 women in 2011 in the UK. There are currently no reliable biomarkers available for use in a regular screening assay for ovarian cancer and due to characteristic late presentation (78% in stages III and...
Uloženo v:
| Vydáno v: | Int J Oncol |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
D.A. Spandidos
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4902066/ https://ncbi.nlm.nih.gov/pubmed/27211906 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ijo.2016.3531 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|